Fascinating talk by Dr. Ayesha Shafi #PCFAcademy @PCF_Science on the emerging roles of CRY1, a key negative regulator of the circadian clock, in shaping the metabolic state of prostate cancer. Despite our understanding that virtually every cell in the body functions according to an intricate circadian rhythm, the role of circadian regulators in PCa remains remarkably understudied. The presentation highlighted the potential importance of this biology and raised thought-provoking questions with broad translational implications. We are left wondering how should the time of biospecimen collection influence our interpretation of patient data? Should treatment administration be optimized according to circadian timing? How does the circadian clock shape tumor metabolism, immune modulation, and therapeutic response? An exciting reminder that time itself may be a critical—and often overlooked—variable in cancer biology.